One aspect of Obamacare is the promotion of “comparative effectiveness research.” Intended to compare treatment options, it can benefit patients only if used for informational purposes, and could also be harmful in practice. Read More.
Recent drug shortages have received national attention as patients are forced to wait for vital treatments or substitute an alternative. Read More.
President Barack Obama wants the Joint Committee on Deficit Reduction to kill market competition for prescription drug coverage chosen by workers and retirees in the Federal Employees Health Benefits Program. Read More.